医学
列线图
终末期肾病
血液透析
疾病
重症监护医学
内科学
阶段(地层学)
心脏病学
期限(时间)
肾脏疾病
量子力学
生物
物理
古生物学
作者
Xu You,Baohuan Gu,Tianlu Chen,Xiangyong Li,Guoxiang Xie,Chao Sang,Hequn Zou
出处
期刊:Annals of palliative medicine
[AME Publishing Company]
日期:2021-03-01
卷期号:10 (3): 3142-3153
被引量:7
摘要
Background: Chronic kidney disease (CKD) is a leading public health problem worldwide. Cardiovascular diseases are the primary cause of death in hemodialysis patients with CKD. Therefore, it is necessary to develop a simple risk assessment tool for cardiovascular events in hemodialysis patients with CKD.Methods: A cohort of 370 hemodialysis patients, who were recruited between January 2015 to September 2019 in south China, were involved in the present study. On the basis of routine blood test indicators and ultrasonic cardiogram parameters, the optimal parameter set was determined and a Cox proportional hazards model coupled with a nomogram was used to predict cardiovascular risk over 3, 5, and 10 years. Predictive performance was evaluated using Harrell's concordance index (C-index) and the area under the receiver-operating characteristic curve (AUROC). The results were validated using both 10-fold cross-validation and hold-out validation (70% training and 30% validation, repeated 100 times).Results: The optimal parameter set consisted of hypertension, diabetes mellitus, age, phosphate, triglyceride, C-reactive protein, white blood cells, and interventricular septum thickness. The time-dependent AUROCs for predicting 3-, 5-, and 10-year cardiovascular event occurrence risk were 0.836, 0.845, and 0.869, respectively. The nomogram showed satisfactory prediction performance (C-index: 0.808, 95% confidence interval: 0.773–0.844) and was well-calibrated. The results were further confirmed by 10-fold cross-validation and hold-out validation (C-index: 0.794 and 0.798, respectively).Conclusions: On the basis of several easy-to-detect clinical parameters, we developed a simple and useful nomogram for predicting cardiovascular risk in long-term hemodialysis patients that is of potential value for clinical application.
科研通智能强力驱动
Strongly Powered by AbleSci AI